The surgical management of glaucoma has been evolving over the past few decades. In an attempt to improve the results of trabeculectomy, a number of modifications have been tried, of which Ologen (Aeon Astron, Leiden, The Netherlands) is one adjunct.1,2 Ologen is being extensively used for filtering surgeries and is known to undergo complete biodegradation within 90–180 days of implantation.3 We report a case of trabeculectomy failure in both eyes (BE) of a patient who had undergone augmented trabeculectomy with Ologen, which was seen to be retained for 10 years postsurgery.
The surgical management of glaucoma has been evolving over the past few decades. In an attempt to improve the results of trabeculectomy, a number of modifications have been tried, of which Ologen (Aeon Astron, Leiden, The Netherlands) is one adjunct.1,2 Ologen is being extensively used for filtering surgeries and is known to undergo complete biodegradation within 90–180 days of implantation.3 We report a case of trabeculectomy failure in both eyes (BE) of a patient who had undergone augmented trabeculectomy with Ologen, which was seen to be retained for 10 years postsurgery.